June 22 (Bloomberg) -- Bloomberg's Shannon Pettypiece reports on Pfizer Inc.'s patent dispute with Teva Pharmaceutical Industries Ltd. over its erectile-dysfunction drug Viagra.
Leerink Swann analyst Seamus Fernandez said in a note today that Pfizer will likely prevail in its fight to block Teva from selling a generic version of the drug. Pettypiece reports on Bloomberg Television's "In the Loop." (Source: Bloomberg)
Leerink Says Pfizer May Win In Viagra Case Against Teva For Country: United States. City: Boston, Buffalo, Downey, El Monte, Pueblo
